ASO Author Reflections: Evolution of Gastric Cancer Care at Tata Memorial Centre-Best of the East and the West.
作者信息
Shrikhande Shailesh V, Batra Swati, Chaudhari Vikram A, Bhandare Manish S
机构信息
Department of Surgical Oncology, Gastrointestinal and HPB Service, Tata Memorial Centre, Homi Bhabha National Institute, Parel, Mumbai, India.
出版信息
Ann Surg Oncol. 2024 Nov;31(12):8183-8184. doi: 10.1245/s10434-024-15929-y. Epub 2024 Aug 4.
Abstract
摘要
相似文献
1
ASO Author Reflections: Evolution of Gastric Cancer Care at Tata Memorial Centre-Best of the East and the West.ASO作者反思：塔塔纪念中心胃癌护理的演变——东西方精华汇聚
Ann Surg Oncol. 2024 Nov;31(12):8183-8184. doi: 10.1245/s10434-024-15929-y. Epub 2024 Aug 4.
2
Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades.印度塔塔纪念中心在宫颈癌照护方面的贡献：二十年历程。
Indian J Med Res. 2021 Aug;154(2):319-328. doi: 10.4103/ijmr.IJMR_339_21.
3
Tata Memorial Hospital: a Peerless Icon.塔塔纪念医院：一座无与伦比的地标。
Indian J Surg Oncol. 2022 Dec;13(Suppl 1):27-29. doi: 10.1007/s13193-022-01588-6. Epub 2022 Jul 27.
4
ASO Author Reflections: Defining Gastrectomy Volume Targets for Regionalization of Gastric Cancer Care in the USA.美国外科医师学会作者反思：确定美国胃癌护理区域化的胃切除术量目标。
Ann Surg Oncol. 2021 Sep;28(9):4848-4849. doi: 10.1245/s10434-021-09760-y. Epub 2021 Mar 1.
5
ASO Author Reflections: A Change Package as a Dissemination Tool for Gastric Cancer Care.
Ann Surg Oncol. 2023 Feb;30(2):1130-1131. doi: 10.1245/s10434-022-12721-8. Epub 2022 Oct 30.
6
ASO Author Reflections: Endoscopic Management Will Be an Effective Treatment Option for Early Remnant Gastric Cancer, Similar to Primary Gastric Cancer.ASO作者反思：与原发性胃癌类似，内镜治疗将成为早期残胃癌的有效治疗选择。
Ann Surg Oncol. 2018 Dec;25(Suppl 3):743-744. doi: 10.1245/s10434-018-6907-6. Epub 2018 Oct 15.
7
ASO Author Reflections: What Is the Best Treatment for Gastric Cancer with Positive Peritoneal Lavage Cytology or Localized Peritoneum Metastasis?ASO作者反思：对于腹腔灌洗细胞学阳性或局限性腹膜转移的胃癌，最佳治疗方法是什么？
Ann Surg Oncol. 2020 Dec;27(Suppl 3):737-738. doi: 10.1245/s10434-019-08054-8. Epub 2019 Dec 4.
8
ASO Author Reflections: CACNA2D1 may have a Potential as a Biomarker for Cancer Growth and as a Therapeutic Target for Gastric Cancer.
Ann Surg Oncol. 2022 Apr 16. doi: 10.1245/s10434-022-11753-4.
9
ASO Author Reflections: Tumor Markers in Gastric Cancer.ASO作者反思：胃癌中的肿瘤标志物
Ann Surg Oncol. 2018 Dec;25(Suppl 3):735-736. doi: 10.1245/s10434-018-6886-7. Epub 2018 Oct 10.
10
ASO Author Reflections: Stage IB Gastric Cancer: More Attention Needed.ASO作者反思：IB期胃癌：需要更多关注
Ann Surg Oncol. 2025 Feb;32(2):1250. doi: 10.1245/s10434-024-16518-9. Epub 2024 Nov 14.
本文引用的文献
1
1657 Resected Gastric Adenocarcinomas at a Single Institution: Outcomes and Trends over 17 Years.一家单中心 17 年 1657 例胃腺癌切除术的结果和趋势。
Ann Surg Oncol. 2024 Oct;31(10):7142-7156. doi: 10.1245/s10434-024-15842-4. Epub 2024 Jul 16.
2
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.氟尿嘧啶+亚叶酸、奥沙利铂和多西紫杉醇与氟尿嘧啶或卡培他滨+顺铂和表柔比星用于局部晚期可切除胃或胃食管交界处腺癌的围手术期化疗（FLOT4）：一项随机、2/3 期试验。
Lancet. 2019 May 11;393(10184):1948-1957. doi: 10.1016/S0140-6736(18)32557-1. Epub 2019 Apr 11.
3
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.胃癌的外科治疗：随机全国性荷兰 D1D2 试验的 15 年随访结果。
Lancet Oncol. 2010 May;11(5):439-49. doi: 10.1016/S1470-2045(10)70070-X. Epub 2010 Apr 19.
4
Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial).腹腔镜与开腹胃癌根治术的近期疗效比较——一项 III 期多中心前瞻性随机对照临床试验（KLASS 试验）
Ann Surg. 2010 Mar;251(3):417-20. doi: 10.1097/SLA.0b013e3181cc8f6b.
Zotero 插件